FENNELL GEORGE
SEC CIK 1521861 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IDXX | Idexx Laboratories | SVP, Chief Revenue Off | 10.7K | — | $16.66M | 14 | 2024-02-08 | 2026-06-01 |
Most active insiders at IDXX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | — | $15.34M |
| 2 | Hunt Nimrata | EVP | — | $9.53M |
| 3 | FENNELL GEORGE | EVP | — | $7.34M |
| 4 | Erickson Michael G | EVP | — | $3.37M |
| 5 | Kingsley Lawrence D | Dir | — | $1.17M |
| 6 | Vandebroek Sophie V. | Dir | — | $920.3K |
| 7 | Emerson Andrew | EVP, CFO, Treas | — | — |
| 8 | Schreck Michael | EVP | — | — |
| 9 | Johnson Michael Perkins | EVP | — | — |
| 10 | Peacock Karen | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 17:00 | 2026-06-01 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | M - OptEx | $0.00 | +639 | 10.7K | +6% | $0 |
| D | 2026-06-02 17:00 | 2026-06-01 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | F - Tax | $566.79 | -284 | 10.4K | -3% | -$161.0K |
| D | 2026-02-17 | 2026-02-14 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | F - Tax | $629.35 | -199 | 10.1K | -2% | -$125.2K |
| DM | 2026-02-17 | 2026-02-14 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | M - OptEx | $0.00 | +454 | 9,878 | +5% | $0 |
| DM | 2026-02-11 | 2026-02-10 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | S - Sale+OE | $646.72 | -11.3K | 14.7K | -44% | -$7.34M |
| DM | 2026-02-11 | 2026-02-09+ | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | M - OptEx | $67.85 | +12.8K | 9,823 | New | +$869.9K |
| DM | 2025-02-18 | 2025-02-14 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | M - OptEx | $0.00 | +304 | 8,227 | +4% | $0 |
| D | 2025-02-18 | 2025-02-14 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | F - Tax | $444.53 | -133 | 8,347 | -2% | -$59.1K |
| DM | 2025-02-11 | 2025-02-07+ | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | M - OptEx | $79.54 | +11.2K | 8,176 | New | +$894.2K |
| D | 2025-02-11 | 2025-02-10 | IDXX | Idexx Laboratories | FENNELL GEORGE | EVP | S - Sale+OE | $462.53 | -9,986 | 8,176 | -55% | -$4.62M |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | FENNELL GEORGE | SVP, Chief Revenue Off | M - OptEx | $0.00 | +370 | 6,820 | +6% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Idexx Laboratories | FENNELL GEORGE | SVP, Chief Revenue Off | F - Tax | $560.56 | -162 | 6,920 | -2% | -$90.8K |
| DM | 2024-02-09 | 2024-02-08 | IDXX | Idexx Laboratories | FENNELL GEORGE | SVP, Chief Revenue Off | S - Sale+OE | $573.87 | -8,198 | 7,124 | -54% | -$4.70M |
| DM | 2024-02-09 | 2024-02-08 | IDXX | Idexx Laboratories | FENNELL GEORGE | SVP, Chief Revenue Off | M - OptEx | $62.00 | +9,810 | 6,712 | New | +$608.2K |
Purchase Sale Sale after option exercise All abbreviations